Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04821310 · ClinicalTrials.gov registry record · Phase 2
Protonix Treatment of Maintenance of Healing in Pediatric Participants Aged 1-11 Years and 12-17 Years
A Phase 2 study, sponsored by Pfizer.
- Terminated
- Registry status
- Phase 2
- Development phase
- 43
- Enrollment target
NCT04821310 is a Phase 2 study that was terminated before completion, run by Pfizer. The registered enrollment target is 43 participants.
The verdict
NCT04821310, a Phase 2 study, was terminated before completion, sponsored by Pfizer.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 43 participants
- Enrollment target
Study Summary
The purpose of this study is to explore the outcomes, tolerability and safety of 2 different doses of oral pantoprazole (full healing dose, half healing dose), assigned based upon weight, for the maintenance of healing of erosive esophagitis in pediatric participants aged 1 to 17 years with endoscopically-confirmed, healed erosive esophagitis.
Interventions
- DRUG Full dose Pantoprazole plus matching placebo
- DRUG Half Dose Pantoprazole plus matching placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2022-01-13 |
| Est. Completion | 2025-12-16 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04821310
The ClinicalTrials.gov registry entry for NCT04821310 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Full dose Pantoprazole plus matching placebo is the first listed.
NCT04821310 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04821310 about?
NCT04821310 is a clinical study titled "Protonix Treatment of Maintenance of Healing in Pediatric Participants Aged 1-11 Years and 12-17 Years". The purpose of this study is to explore the outcomes, tolerability and safety of 2 different doses of oral pantoprazole (full healing dose, half healing dose), assigned based upon weight, for the maintenance of healing of erosive esophagitis in pediatric participants aged 1 to 17 years with endoscop...
What is the current status of trial NCT04821310?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 43 participants. The study started on 2022-01-13. Estimated completion is 2025-12-16.
What interventions are being tested in trial NCT04821310?
The interventions under investigation include: Full dose Pantoprazole plus matching placebo (DRUG), Half Dose Pantoprazole plus matching placebo (DRUG).
Who is sponsoring clinical trial NCT04821310?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.